Eculizumab for patients with paroxysmal nocturnal hemoglobinuria (PNH) is effective during the maintenance of hemodialysis for end stage renal failure

  1. Lookup NU author(s)
  2. Dr Suren Kanagasundaram
Author(s)Kelly RJ, Hill A, Arnold LM, Khursigara G, Kanagasundaram NS, Hillmen P
Publication type Article
JournalLeukemia Research
Year2011
Volume35
Issue4
Pages560-562
ISSN (print)0145-2126
ISSN (electronic)1873-5835
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherPergamon
URLhttp://dx.doi.org/10.1016/j.leukres.2010.10.021
DOI10.1016/j.leukres.2010.10.021
NotesCase of the month
Actions    Link to this publication
Share